# HBT Financial, Inc.: financial statements, quarterly

HBT · Nasdaq · CIK 775215 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hbt.md) · [Financials](/companies/hbt/financials.md) · [Filings](/companies/hbt/filings.md) · [Insiders](/companies/hbt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hbt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [10.8](/filings/0001628280-23-036704.md) | [14.3 d](/filings/0001628280-24-009388.md) | [15.3](/filings/0001628280-24-019634.md) | [15.8](/filings/0001628280-24-034168.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [6.9](/filings/0001628280-24-044316.md) | [6.3 d](/filings/0000775215-26-000025.md) | [5.3](/filings/0000775215-25-000020.md) | [6.9](/filings/0000775215-25-000033.md) | [6.3](/filings/0000775215-25-000056.md) | [7.1 d](/filings/0000775215-26-000025.md) | [6.4](/filings/0000775215-26-000055.md) | [7.1](/filings/0000775215-26-000069.md) | [7.0](/filings/0000775215-25-000056.md) | [7.0 d](/filings/0000775215-26-000025.md) | [3.9](/filings/0000775215-26-000055.md) | [9.9](/filings/0000775215-26-000069.md) |
| Net income | $m | [19.7](/filings/0001628280-24-044316.md) | [18.4 d](/filings/0000775215-26-000025.md) | [15.3](/filings/0000775215-25-000020.md) | [18.1](/filings/0000775215-25-000033.md) | [18.2](/filings/0000775215-25-000056.md) | [20.3 d](/filings/0000775215-26-000025.md) | [19.1](/filings/0000775215-26-000055.md) | [19.2](/filings/0000775215-26-000069.md) | [19.8](/filings/0000775215-25-000056.md) | [18.9 d](/filings/0000775215-26-000025.md) | [11.2](/filings/0000775215-26-000055.md) | [27.8](/filings/0000775215-26-000069.md) |
| Diluted EPS | $ per share | [0.62](/filings/0001628280-24-044316.md) | not reported | [0.48](/filings/0000775215-25-000020.md) | [0.57](/filings/0000775215-25-000033.md) | [0.57](/filings/0000775215-25-000056.md) | not reported | [0.60](/filings/0000775215-26-000055.md) | [0.61](/filings/0000775215-26-000069.md) | [0.63](/filings/0000775215-25-000056.md) | not reported | [0.34](/filings/0000775215-26-000055.md) | [0.76](/filings/0000775215-26-000069.md) |
| Basic EPS | $ per share | [0.62](/filings/0001628280-24-044316.md) | not reported | [0.48](/filings/0000775215-25-000020.md) | [0.57](/filings/0000775215-25-000033.md) | [0.58](/filings/0000775215-25-000056.md) | not reported | [0.60](/filings/0000775215-26-000055.md) | [0.61](/filings/0000775215-26-000069.md) | [0.63](/filings/0000775215-25-000056.md) | not reported | [0.34](/filings/0000775215-26-000055.md) | [0.77](/filings/0000775215-26-000069.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [112](/filings/0001628280-23-036704.md) | [141](/filings/0001628280-25-011264.md) | [260](/filings/0001628280-24-019634.md) | [195](/filings/0001628280-24-034168.md) | [180](/filings/0001628280-24-044316.md) | [138](/filings/0000775215-26-000025.md) | [212](/filings/0000775215-25-000020.md) | [196](/filings/0000775215-25-000033.md) | [155](/filings/0000775215-25-000056.md) | [122](/filings/0000775215-26-000069.md) | [288](/filings/0000775215-26-000055.md) | [132](/filings/0000775215-26-000069.md) |
| Total assets | $m | [4,992](/filings/0001628280-23-036704.md) | [5,073](/filings/0001628280-25-011264.md) | [5,041](/filings/0001628280-24-019634.md) | [5,006](/filings/0001628280-24-034168.md) | [4,991](/filings/0001628280-24-044316.md) | [5,033](/filings/0000775215-26-000025.md) | [5,092](/filings/0000775215-25-000020.md) | [5,018](/filings/0000775215-25-000033.md) | [5,035](/filings/0000775215-25-000056.md) | [5,071](/filings/0000775215-26-000069.md) | [6,774](/filings/0000775215-26-000055.md) | [6,728](/filings/0000775215-26-000069.md) |
| Total liabilities | $m | [4,536](/filings/0001628280-23-036704.md) | [4,584](/filings/0001628280-25-011264.md) | [4,544](/filings/0001628280-24-019634.md) | [4,497](/filings/0001628280-24-034168.md) | [4,453](/filings/0001628280-24-044316.md) | [4,488](/filings/0000775215-26-000025.md) | [4,527](/filings/0000775215-25-000020.md) | [4,438](/filings/0000775215-25-000033.md) | [4,436](/filings/0000775215-25-000056.md) | [4,456](/filings/0000775215-26-000069.md) | [6,026](/filings/0000775215-26-000055.md) | [5,963](/filings/0000775215-26-000069.md) |
| Shareholders' equity | $m | [456](/filings/0001628280-24-044316.md) | [489](/filings/0000775215-26-000025.md) | [497](/filings/0000775215-25-000033.md) | [509](/filings/0000775215-25-000056.md) | [538](/filings/0000775215-25-000056.md) | [545](/filings/0000775215-26-000069.md) | [565](/filings/0000775215-26-000069.md) | [581](/filings/0000775215-26-000069.md) | [599](/filings/0000775215-25-000056.md) | [615](/filings/0000775215-26-000069.md) | [747](/filings/0000775215-26-000069.md) | [765](/filings/0000775215-26-000069.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.7 d](/filings/0001628280-24-044316.md) | [13.0 d](/filings/0000775215-26-000025.md) | [26.8](/filings/0000775215-25-000020.md) | [19.8 d](/filings/0000775215-25-000033.md) | [25.5 d](/filings/0000775215-25-000056.md) | [17.3 d](/filings/0000775215-26-000025.md) | [30.4](/filings/0000775215-26-000055.md) | [13.6 d](/filings/0000775215-26-000069.md) | [17.2 d](/filings/0000775215-25-000056.md) | [23.9 d](/filings/0000775215-26-000025.md) | [28.5](/filings/0000775215-26-000055.md) | [17.2 d](/filings/0000775215-26-000069.md) |
| Dividends paid | $m | [5.4 d](/filings/0001628280-24-044316.md) | [5.4 d](/filings/0000775215-26-000025.md) | [6.1](/filings/0000775215-25-000020.md) | [6.0 d](/filings/0000775215-25-000033.md) | [6.0 d](/filings/0000775215-25-000056.md) | [6.0 d](/filings/0000775215-26-000025.md) | [6.7](/filings/0000775215-26-000055.md) | [6.6 d](/filings/0000775215-26-000069.md) | [6.7 d](/filings/0000775215-25-000056.md) | [6.6 d](/filings/0000775215-26-000025.md) | [7.3](/filings/0000775215-26-000055.md) | [8.4 d](/filings/0000775215-26-000069.md) |
| Share repurchases | $m | [1.7 d](/filings/0001628280-24-044316.md) | [1.4 d](/filings/0000775215-26-000025.md) | [3.4](/filings/0000775215-25-000020.md) | [1.0 d](/filings/0000775215-25-000033.md) | [0.0 d](/filings/0000775215-25-000056.md) | [0.0 d](/filings/0000775215-26-000025.md) | [0.0](/filings/0000775215-26-000055.md) | [2.9 d](/filings/0000775215-26-000069.md) | [1.0 d](/filings/0000775215-25-000056.md) | [0.6 d](/filings/0000775215-26-000025.md) | [15.7](/filings/0000775215-26-000055.md) | [0.4 d](/filings/0000775215-26-000069.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.9](/filings/0001628280-23-036704.md) | [31.0](/filings/0001628280-24-019634.md) | [32.1](/filings/0001628280-24-034168.md) | [32.0](/filings/0001628280-24-044316.md) | [31.8](/filings/0000775215-25-000020.md) | [31.7](/filings/0000775215-25-000033.md) | [31.7](/filings/0000775215-25-000056.md) | [31.7](/filings/0000775215-26-000055.md) | [31.6](/filings/0000775215-26-000069.md) | [31.6](/filings/0000775215-25-000056.md) | [33.3](/filings/0000775215-26-000055.md) | [36.5](/filings/0000775215-26-000069.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,365,612 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0000775215-26-000069.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.